Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
about
Diarrheagenic Escherichia coliSafety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coliShiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.Management of hemolytic-uremic syndrome in childrenNatural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome.Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndromeDevelopment of an experimental hemolytic uremic syndrome in rats.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003.Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods.Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans.Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.Inhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources.Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigatorsThe role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coliVirulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse modelPrevalence and virulence factors of Escherichia coli serogroups O26, O103, O111, and O145 shed by cattle in Scotland.Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccinesConstruction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethalityImmune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome.Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR.The non-O157 shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens.Genetic basis of virulence in Shigella species.Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84).Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.
P2860
Q24533466-F5155982-835E-4E0B-8136-7CEC84C0C13CQ24653814-41811C79-9981-4FC5-9438-DB3D3EA4B0ADQ24658046-8175B298-FE14-4640-AB2E-6BEBA7B63B4DQ27002576-FA48980B-DF4E-4B78-AEF7-B5892BD0D800Q30300135-808C9942-A499-47D8-A41B-77E6E94F71A6Q30449794-F2A2EA31-DBED-46A4-97ED-0B26F0D9E01EQ33359241-043D6A5D-BFE1-4402-9386-AC6C8B4CFB03Q33359877-881BD5B9-F24C-45C5-9930-FA45D719A530Q33364452-8757BF03-B25D-4C55-96F8-651B0C1A74E8Q33369261-34F2C209-E85D-4860-A9D4-D38F125E2B90Q33378553-DE8A6D52-1668-4E55-AB47-0976F4C4ECC6Q33379319-FA9BF447-AA62-47AF-A461-400FFAB5DCBCQ33386652-81F00EE8-4C7B-447F-9FDB-A49C1B6081C4Q33395264-A13E4DA2-C0EC-4AC9-B45A-BA1F7FF3397BQ33395389-7C3D0BD5-FB8F-48A8-95C5-F515A93E22A9Q33397728-15FE355A-DAFA-4209-A90A-79B0D0A37012Q33403923-D8A626D3-4A2D-431D-8337-267F973EF086Q33408179-A1690EDE-558A-487C-85CB-7D4836A40E65Q33488390-3D24BBE6-C13A-49D0-8FBA-67D162714783Q33492004-38DEE3C5-1C78-4D05-9665-DED510D9287EQ33494314-97C6F9D1-ECBB-4336-9CB7-711E0A06C115Q33494317-6C56CF8F-F166-44F3-8C94-677A30F93262Q33494653-3D1A60FD-BB0E-4D9D-8B22-6E7F3C1A170AQ33500218-0DAB04FF-B615-4801-9CD9-8B8CD473109FQ33608157-AC3A9F83-F620-49B9-92C8-97E3FBEA9BD0Q34316000-90B0A3FB-8A03-4701-BED4-46134F4C3877Q34545082-DD0219E6-BFF7-45AE-85A7-BE687D4DF443Q35548702-6C598D8A-CE72-4420-83C7-A25B1A0AFA6AQ35773392-0311CCFF-1890-45DC-9D39-F9EB506817A5Q35892930-053D8D4D-E990-448F-9554-2BDD686E7D7BQ35923378-62BE268D-365A-4C9C-98CA-6AF734FBA8F6Q36521591-048C6BB9-15D7-43B4-A1C8-CEC8CFA8AC5CQ36672988-4C7D7C55-ADD5-4233-A99B-938773CE2BFEQ36799514-7CB8F0AB-6A61-486B-8C20-608C58B0D2F4Q37295263-1121ABE6-EE27-4172-8F10-8468410CDA1DQ39432827-910502FB-50FF-417B-BC0F-DA82167E49F4Q39830255-7781F86E-3372-4195-A038-0DF51CE4B219Q40146295-805D772B-487B-4B19-A949-74FFFF925FBEQ42859529-BA503C6C-44D9-4333-BC6D-D169925B446EQ51375879-59C0366B-85CD-4280-936D-C5BA09D83DBA
P2860
Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@ast
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@en
type
label
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@ast
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@en
prefLabel
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@ast
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@en
P2093
P356
P1476
Hemolytic uremic syndrome and ...... the role of Shiga-like toxins.
@en
P2093
Ashkenazi S
Grinstein S
Mendilaharzu F
Rubeglio E
P304
P356
10.1093/INFDIS/160.3.469
P407
P577
1989-09-01T00:00:00Z